Item 8.01 Other Events.
On
Item 9.01 Financial Statements and Exhibits
(d) Exhibit Exhibit No. Description 99.1 Press Release of uniQure N.V. datedFebruary 7, 2022 announcing the dosing of first patients in the European open-label clinical trial of AMT-130 gene therapy in Huntington's Disease. 104 Cover Page Interactive Data File (embedded with the Inline XBRL document). 2
© Edgar Online, source